Association of a functional polymorphism of PTPN22 encoding a lymphoid protein phosphatase in bilateral Meniere's disease

✍ Scribed by Jose A. Lopez-Escamez; Pablo Saenz-Lopez; Lourdes Acosta; Antonia Moreno; Irene Gazquez; Herminio Perez-Garrigues; Alicia Lopez-Nevot; Miguel A. Lopez-Nevot

• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 83 KB
• Volume: 120
• Category: Article
• ISSN: 0023-852X
• DOI: 10.1002/lary.20650

✦ Synopsis

Abstract

Objectives/Hypothesis:

Bilateral Meniere's disease (BMD) is a severe disease that usually results in bilateral severe or profound sensorineural hearing loss and chronic disequilibrium with loss of vestibular function. We examined single nucleotide polymorphisms (SNPs) in the PTPN22 and CTLA4 genes in Caucasian patients with BMD to assess the possible association between these polymorphism and the predisposition and clinical expression of this disease.

Study Design:

A case control study.

Methods:

The functional protein tyrosine phosphatase type 22 (PTPN22) SNP (rs2476601, 1858C/T) and CTLA4 SNP (rs231775, 49A/G) were analyzed in 52 patients with BMD and 348 healthy controls by a TaqMan 5′ allelic discrimination assay. Data were analyzed by a χ^2^ test with Fisher exact test.

Results:

No association was found between the +49A/G CTLA4 genotype and BMD patients. However, the heterozygote PTPN22 1858C/T genotype was present at a significantly higher frequency in BMD patients than in controls (odds ratio = 2.25, 95% confidence interval: 1.09–4.62; P = .04).

Conclusions:

These results suggest that the PTPN22 1858C/T genotype may confer differential susceptibility to BMD in the Spanish population and support an autoimmune etiology for BMD. Laryngoscope, 2010